View in EDS HTML Full Text PDF Full Text

Letter: cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization.

Saved in:
Bibliographic Details
Title: Letter: cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization.
Authors: He, Z.‐H.1, He, W.‐R.2, Wu, L.‐L.3, Zhao, C.4, Peng, N.‐F.4, Ahir, B.‐K.5, Lu, C.‐Y.1 lucaiyun2000@126.com
Source: Alimentary Pharmacology & Therapeutics. Jan2017, Vol. 45 Issue 1, p183-184. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.13820